We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Diabetes & Endocrinology

Diabetes & Endocrinology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial
Diabetes & EndocrinologyCONDOR trialproliferative diabetic retinopathy

Brolucizumab Outperforms Laser Therapy in Proliferative Diabetic Retinopathy: Insights from the CONDOR Trial

By MedXY|Apr 27, 2026

The CONDOR trial demonstrates brolucizumab’s superiority over panretinal photocoagulation in preserving vision and reducing disease progression in proliferative diabetic retinopathy, offering a potential shift in treatment paradigms.

68Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery
Diabetes & Endocrinology68Ga-pentixafor PET/CTadrenalectomy

68Ga-Pentixafor PET/CT Predicts Postoperative Outcomes in Primary Aldosteronism Surgery

By MedXY|Apr 26, 2026

68Ga-pentixafor PET/CT parameters correlate with clinical success post-adrenalectomy in primary aldosteronism, offering prognostic insights linked to histopathologic subtypes and CXCR4 expression.

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes
Diabetes & EndocrinologyGLP-1 receptor agonistMASLD

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes

By MedXY|Apr 25, 2026

A study reveals that combining GLP-1 receptor agonists with SGLT-2 inhibitors significantly lowers the risk of major adverse liver and cardiovascular outcomes in patients with MASLD and type 2 diabetes compared to monotherapy.

uGMI: A More Accurate Alternative to HbA1c for Diabetes Management
Diabetes & Endocrinologycontinuous glucose monitoringdiabetes

uGMI: A More Accurate Alternative to HbA1c for Diabetes Management

By MedXY|Apr 24, 2026

The updated glucose management indicator (uGMI) significantly improves alignment with HbA1c, reducing discordance, particularly in high and low glucose ranges, offering clinicians a more reliable tool for diabetes monitoring.

Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome
Diabetes & Endocrinologyair pollutionbody composition

Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome

By MedXY|Apr 24, 2026

A study of 1,454 older adults with metabolic syndrome reveals that long-term exposure to air pollutants like black carbon, PM2.5, and NO2 is associated with increased fat mass and decreased lean mass, persisting over three years, particular

Reevaluating TSH-FT4 Dynamics: New Evidence Challenges Traditional Reference Intervals
Diabetes & Endocrinologyfree thyroxinereference intervals

Reevaluating TSH-FT4 Dynamics: New Evidence Challenges Traditional Reference Intervals

By MedXY|Apr 22, 2026

A retrospective study reveals that the TSH-FT4 relationship is segmented, not log-linear, with implications for refining thyroid function test interpretation and reference intervals.

Hospital Delays in Glucose Checks and Insulin Dosing: Do They Impact Patient Care?
Diabetes & Endocrinologycontinuous glucose monitordiabetes management

Hospital Delays in Glucose Checks and Insulin Dosing: Do They Impact Patient Care?

By MedXY|Apr 22, 2026

Study reveals significant time gaps between fingerstick glucose tests and insulin administration in hospitals, with nearly 30% of cases potentially receiving incorrect insulin doses due to changing glucose levels during delays.

Somatostatin in the Gut: No Diabetes-Specific Patterns Found
Diabetes & Endocrinologyintestinal mucosasomatostatin

Somatostatin in the Gut: No Diabetes-Specific Patterns Found

By MedXY|Apr 22, 2026

New study reveals uniform distribution of somatostatin and its receptors throughout the intestinal tract in both healthy individuals and type 2 diabetes patients, challenging previous assumptions about its role in diabetes pathophysiology.

Childhood BMI Trajectories Strongly Predict Adult Metabolic Multimorbidity: A 36-Year Cohort Study Reveals Life-Course Risk Patterns
Diabetes & EndocrinologyBMI trajectorylife-course epidemiology

Childhood BMI Trajectories Strongly Predict Adult Metabolic Multimorbidity: A 36-Year Cohort Study Reveals Life-Course Risk Patterns

By MedXY|Apr 22, 2026

A 36-year prospective study demonstrates that cumulative BMI burden from childhood to adulthood significantly elevates risks of metabolic multimorbidity, with distinct life-stage patterns and sex-specific vulnerabilities.

Efficacy and Safety of Cagrilintide-Semaglutide Combination vs Semaglutide Alone for Weight Management in East Asian Adults with Overweight/Obesity: REDEFINE 5 Trial
Diabetes & Endocrinologyamylin analogueGLP-1/胰高血糖素激动剂

Efficacy and Safety of Cagrilintide-Semaglutide Combination vs Semaglutide Alone for Weight Management in East Asian Adults with Overweight/Obesity: REDEFINE 5 Trial

By MedXY|Apr 22, 2026

Phase 3a trial in Japan/Taiwan shows cagrilintide-semaglutide combination delivers superior weight loss (18.4%) versus semaglutide alone (11.9%) in adults with overweight/obesity ± type 2 diabetes, with comparable safety profiles dominated

Produce Prescription for Diabetes Falls Short in Improving Health Outcomes
Diabetes & EndocrinologydiabetesProduce Prescription

Produce Prescription for Diabetes Falls Short in Improving Health Outcomes

By MedXY|Apr 21, 2026

A randomized trial found that a $80 monthly produce prescription did not significantly improve HbA1c levels or reduce healthcare utilization in diabetic patients at risk of food insecurity.

Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights
Diabetes & Endocrinologydiabetesdiet intervention

Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights

By MedXY|Apr 18, 2026

A Greenlandic study shows that Inuit with a specific sucrase-isomaltase gene variant have better glucose regulation on a Western diet compared to non-carriers, suggesting potential new diabetes treatments.

Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma
Diabetes & EndocrinologyATA guidelinesPapillary Thyroid Carcinoma

Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma

By MedXY|Apr 18, 2026

A real-world study validates the 2025 ATA thyroid cancer risk guidelines, showing significant patient reclassification and identifying a new ‘low-intermediate-risk’ group needing tailored management approaches.

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts
Diabetes & EndocrinologyATA guidelinesPapillary Thyroid Carcinoma

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts

By MedXY|Apr 18, 2026

A retrospective study of 670 papillary thyroid carcinoma patients validates the 2025 ATA risk stratification system, demonstrating a shift toward higher-risk classifications. The new ‘low-intermediate-risk’ class emerges as a di

No Clear Winner: Real-World Evidence Shows GLP-1RAs and SGLT2 Inhibitors Deliver Comparable Cardiovascular Benefits in Type 2 Diabetes
Cardiologycardiovascular outcomescomparative effectiveness

No Clear Winner: Real-World Evidence Shows GLP-1RAs and SGLT2 Inhibitors Deliver Comparable Cardiovascular Benefits in Type 2 Diabetes

By MedXY|Apr 18, 2026

A large-scale multinational study of over 1.2 million patients reveals that individual GLP-1 receptor agonists and SGLT2 inhibitors offer broadly similar cardiovascular protection in type 2 diabetes, challenging assumptions about meaningful

Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency
Diabetes & EndocrinologyCUBN Genemetformin

Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency

By MedXY|Apr 17, 2026

Researchers have identified a genetic variant in the cubilin gene (CUBN, rs1801222) that significantly increases the risk of metformin-induced vitamin B12 deficiency, with carriers of the AA genotype experiencing deficiency up to twice as f

Testosterone-Augmented Exercise Shows Promise for Muscle Mass and Anemia in Spinal Cord Injury Patients
Diabetes & Endocrinologyexercise rehabilitationFES cycling

Testosterone-Augmented Exercise Shows Promise for Muscle Mass and Anemia in Spinal Cord Injury Patients

By MedXY|Apr 17, 2026

A 16-week home-based trial combining testosterone with functional electrical stimulation and arm ergometry improved lean mass and corrected anemia in spinal cord injury patients, though aerobic capacity gains were not statistically signific

Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex
Diabetes & Endocrinologydevelopmental milestonesGestational Diabetes

Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex

By MedXY|Apr 17, 2026

A nationwide cohort study of 466,462 infants reveals that maternal pregestational diabetes significantly increases the risk of delayed developmental milestones, with type 1 diabetes conferring the highest risk and female offspring showing p

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know
Diabetes & EndocrinologyEmotional functioningoncology

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know

By MedXY|Apr 13, 2026

A prospective study identifies exhaustion, head and neck discomfort, and body image concerns as independent predictors of poor emotional functioning in differentiated thyroid carcinoma patients. These findings highlight actionable targets f

Rising Tide of Primary Hyperparathyroidism: Stockholm Study Reveals Dramatic Increase in Incidence and Prevalence Over 15 Years
Diabetes & Endocrinologyepidemiologyincidence

Rising Tide of Primary Hyperparathyroidism: Stockholm Study Reveals Dramatic Increase in Incidence and Prevalence Over 15 Years

By MedXY|Apr 13, 2026

A landmark population-based study spanning 2006-2020 in Stockholm, Sweden, reveals that biochemically confirmed primary hyperparathyroidism incidence increased by 52% while only half of affected patients received clinical diagnosis, highlig

Prev
18 / 25
1…1617181920…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles